P. Thavasu - Concepedia

Author

P. Thavasu

The Honourable Society of Lincoln's Inn

Also Known As

P Thavasu, P. THAVASU, P. Thavasu, P. W. Thavasu, P.W. Thavasu, PW Thavasu

Publications

799

Citations

H-Index

Concepts

All Affiliations

The Honourable Society of Lincoln's Inn Cancer Research UK Churchill Hospital Royal Marsden NHS Foundation Trust Institute of Cancer Research

About

P. Thavasu is an author at The Honourable Society of Lincoln's Inn specializing in medicine, inflammation, and biomedical analysis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	261
2	Cell Biology	1	1	28
3	Immunology	1	1	233
4	Medical Laboratory Science	1	1	233
5	Autoimmune Disease	1	1	233

P. Thavasu

Publications

789

Citations

H-Index

Page 1

	Year	Citations
Measuring cytokine levels in blood P. Thavasu, S.J. Longhurst, S.P. Joel, Journal of Immunological Methods InflammationCytokine LevelsCytokineAutoimmune DiseaseMedicine	1992	233
Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C David Propper, A. McDonald, A. Man, Journal of Clinical Oncology	2001	233
Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor Induction In Vivo P. A. Philip, Daniel Rea, P. Thavasu, JNCI Journal of the National Cancer Institute	1993	187
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer Philip H. Jones, K Christodoulos, Nicola Dobbs, British Journal of Cancer	2004	40
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines M. Puglisi, P. Thavasu, Andrew N. Stewart, Lung Cancer Growth-inhibitory EffectsMedicineAkt InhibitionCell DeathCancer Biology	2014	28
Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin‐2 David Miles, Louise Thomsen, Frances R. Balkwill, European Journal of Clinical Investigation	1994	26
Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors Andrew N. Stewart, P. Thavasu, Johann S. de Bono, Annals of Oncology	2015	23
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents Víctor Moreno, P. Thavasu, M. Blanco Codesido, British Journal of Cancer	2012	19

Page 1